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SCIENTIFIC NOTE 
Effect of Protein Binding on Steady-State Equations 
John G. Wagner 1 
Received July 2, 1985--September 3, 1985 
Previously published steady-state equations assumed elimination of  total drug. The equations have 
been derived to cover the case where only free (unbound) drug is eliminated. The equation for 
oral administration is the same in both eases. The equation for intravenous administration has 
the same form, but the interpretation of K m is different. 
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In the article by Wagner et  al. (1) it was assumed that total drug was 
eliminated from the liver. Gibaldi and Koup (2) derived their Eqs. (11) and 
(12) assuming only free drug was eliminated in the liver. If  we make the 
same assumption as Gibaldi and Koup, then our Eq. (30) remains the same, 
but could also be written as 
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2, K',~ is the Michaelis-Menten constant in terms of free drug, and the f 
refers to free (unbound) drug. 
Our Eq. (5) would become 
I v = R o +  K L R o  
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where K ~  = ( f J f O K , ,  = K ' / f l  and fl  is the free fraction in blood compart- 
ment 1. Thus, iff~ were measured in blood, then K'm could be estimated, 
otherwise K~  would be estimated. Mso, ( K ~ ) I v / ( K m ) p o  = f 2 / f I  and if f l  is 
measured directly in blood, then f2 could be estimated. 
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It should be carefully noted that we define the intrinsic clearance of 
free drug CL{ as CLi/f,  where CLi is the intrinsic clearance of total drug. 
Hence our Eq. (49) could be written as 
QCL, Qf.CL{ 
CLH - Q + CL, - Q + f ,  CL { 
Thus, this obviates the statement of Gibaldi and Koup (2) that writing it 
as QCLJ(Q+CLi)  means that drug clearance is independent of drug 
binding. Similarly, in the symbolism of Gibaldi and Koup (2), we would 
write CL~ =f~CL'~. Our definition and equation above agree with the theory 
and experimental data of Levy and Yacobi (3), who reported that a plot 
of the clearance of  total warfarin versus the fraction unbound gave a linr 
plot with slope equal to the intrinsic clearance of free drug; this in our 
symbolism is equivalent to CL~ =f~. CL{. 
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